190 related articles for article (PubMed ID: 36344723)
1. Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia.
Skovgård K; Barrientos SA; Petersson P; Halje P; Cenci MA
Neurotherapeutics; 2023 Jan; 20(1):304-324. PubMed ID: 36344723
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
Dupre KB; Cruz AV; McCoy AJ; Delaville C; Gerber CM; Eyring KW; Walters JR
Neurobiol Dis; 2016 Feb; 86():1-15. PubMed ID: 26586558
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia.
Dwi Wahyu I; Chiken S; Hasegawa T; Sano H; Nambu A
J Neurosci; 2021 Mar; 41(12):2668-2683. PubMed ID: 33563724
[TBL] [Abstract][Full Text] [Related]
4. Eltoprazine modulated gamma oscillations on ameliorating L-dopa-induced dyskinesia in rats.
Bi Y; Wang P; Yu J; Wang Z; Yang H; Deng Y; Guan J; Zhang W
CNS Neurosci Ther; 2023 Oct; 29(10):2998-3013. PubMed ID: 37122156
[TBL] [Abstract][Full Text] [Related]
5. Eltoprazine prevents levodopa-induced dyskinesias by reducing causal interactions for theta oscillations in the dorsolateral striatum and substantia nigra pars reticulate.
Wang Q; Chen J; Li M; Lv S; Xie Z; Li N; Wang N; Wang J; Luo F; Zhang W
Neuropharmacology; 2019 Apr; 148():1-10. PubMed ID: 30612008
[TBL] [Abstract][Full Text] [Related]
6. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
Frau R; Savoia P; Fanni S; Fiorentini C; Fidalgo C; Tronci E; Stancampiano R; Meloni M; Cannas A; Marrosu F; Bortolato M; Devoto P; Missale C; Carta M
Exp Neurol; 2017 May; 291():1-7. PubMed ID: 28131725
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
Andreoli L; Abbaszadeh M; Cao X; Cenci MA
Neurobiol Dis; 2021 Sep; 157():105429. PubMed ID: 34153463
[TBL] [Abstract][Full Text] [Related]
8. Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB
Leija-Salazar M; Bermúdez de León M; González-Horta A; González-Hernández B
Pharmacol Biochem Behav; 2020 Jul; 194():172950. PubMed ID: 32413434
[TBL] [Abstract][Full Text] [Related]
9. Fenobam modulates distinct electrophysiological mechanisms for regulating excessive gamma oscillations in the striatum of dyskinetic rats.
Wang P; Dai W; Liu H; Liu H; Xu Y
Exp Neurol; 2024 Aug; 378():114833. PubMed ID: 38782350
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
11. Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia.
Bastide MF; Dovero S; Charron G; Porras G; Gross CE; Fernagut PO; Bézard E
Neurobiol Dis; 2014 Feb; 62():179-92. PubMed ID: 24103779
[TBL] [Abstract][Full Text] [Related]
12. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H
J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596
[TBL] [Abstract][Full Text] [Related]
13. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.
Kumar R; Riddle LR; Griffin SA; Chu W; Vangveravong S; Neisewander J; Mach RH; Luedtke RR
Neuropharmacology; 2009; 56(6-7):956-69. PubMed ID: 19371586
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
Mango D; Bonito-Oliva A; Ledonne A; Cappellacci L; Petrelli R; Nisticò R; Berretta N; Fisone G; Mercuri NB
Exp Neurol; 2014 Nov; 261():733-43. PubMed ID: 25173217
[TBL] [Abstract][Full Text] [Related]
16. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C
Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645
[TBL] [Abstract][Full Text] [Related]
17. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats.
Aristieta A; Ruiz-Ortega JA; Miguelez C; Morera-Herreras T; Ugedo L
Neurobiol Dis; 2016 May; 89():88-100. PubMed ID: 26852950
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
Lundblad M; Usiello A; Carta M; Håkansson K; Fisone G; Cenci MA
Exp Neurol; 2005 Jul; 194(1):66-75. PubMed ID: 15899244
[TBL] [Abstract][Full Text] [Related]
19. Site-specific action of L-3,4-dihydroxyphenylalanine in the striatum but not globus pallidus and substantia nigra pars reticulata evokes dyskinetic movements in chronic L-3,4-dihydroxyphenylalanine-treated 6-hydroxydopamine-lesioned rats.
Buck K; Voehringer P; Ferger B
Neuroscience; 2010 Mar; 166(2):355-8. PubMed ID: 20026252
[TBL] [Abstract][Full Text] [Related]
20. Dyskinesia is Closely Associated with Synchronization of Theta Oscillatory Activity Between the Substantia Nigra Pars Reticulata and Motor Cortex in the Off L-dopa State in Rats.
Chen J; Wang Q; Li N; Huang S; Li M; Cai J; Wang Y; Wen H; Lv S; Wang N; Wang J; Luo F; Zhang W
Neurosci Bull; 2021 Mar; 37(3):323-338. PubMed ID: 33210188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
